Ana Luiza M. Amorim , Nadia C. Cabral , Fabiane M. Osaku , Claudio A. Len , Enedina M.L. Oliveira , Maria Teresa Terreri
{"title":"小儿人群脱髓鞘疾病与自身免疫性风湿性疾病的关系","authors":"Ana Luiza M. Amorim , Nadia C. Cabral , Fabiane M. Osaku , Claudio A. Len , Enedina M.L. Oliveira , Maria Teresa Terreri","doi":"10.1016/j.rbr.2016.08.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population.</p></div><div><h3>Objective</h3><p>To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients.</p></div><div><h3>Method</h3><p>22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto‐antibodies.</p></div><div><h3>Results</h3><p>Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first‐degree relatives. ANA was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of ANA‐positive patients were diagnosed with rheumatologic autoimmune disieses.</p></div><div><h3>Conclusion</h3><p>Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of ANA positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults.</p></div>","PeriodicalId":48991,"journal":{"name":"Revista Brasileira De Reumatologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rbr.2016.08.004","citationCount":"4","resultStr":"{\"title\":\"Associação entre doença desmielinizante e doença reumática autoimune em uma população pediátrica\",\"authors\":\"Ana Luiza M. Amorim , Nadia C. Cabral , Fabiane M. Osaku , Claudio A. Len , Enedina M.L. Oliveira , Maria Teresa Terreri\",\"doi\":\"10.1016/j.rbr.2016.08.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population.</p></div><div><h3>Objective</h3><p>To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients.</p></div><div><h3>Method</h3><p>22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto‐antibodies.</p></div><div><h3>Results</h3><p>Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first‐degree relatives. ANA was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of ANA‐positive patients were diagnosed with rheumatologic autoimmune disieses.</p></div><div><h3>Conclusion</h3><p>Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of ANA positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults.</p></div>\",\"PeriodicalId\":48991,\"journal\":{\"name\":\"Revista Brasileira De Reumatologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rbr.2016.08.004\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Brasileira De Reumatologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0482500416300833\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira De Reumatologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0482500416300833","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}
Associação entre doença desmielinizante e doença reumática autoimune em uma população pediátrica
Introduction
Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population.
Objective
To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients.
Method
22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto‐antibodies.
Results
Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first‐degree relatives. ANA was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of ANA‐positive patients were diagnosed with rheumatologic autoimmune disieses.
Conclusion
Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of ANA positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults.
期刊介绍:
RBR nasceu da necessidade de se criar um órgão oficial da SBR que pudesse divulgar a produção científica dos reumatologistas brasileiros. O primeiro número foi publicado em setembro de 1957. A partir do volume 18 (1978), passou a seis números, com periodicidade atual. A RBR, em sua trajetória, tem sido objeto de constantes mudanças, sempre visando ao seu aprimoramento e revitalização, tanto em sua apresentação como em seu conteúdo.